Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients.
about
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureusIn the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort studySevere sepsis: variation in resource and therapeutic modality use among academic centersSmoking and the outcome of infection.Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.Insulin-treated diabetes is not associated with increased mortality in critically ill patientsRisk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study.Effect of socioeconomic status on mortality after bacteremia in working-age patients. A Danish population-based cohort study.Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive carePredictors of in-hospital mortality in elderly patients with bacteraemia admitted to an Internal Medicine ward.Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortalityUnderlying disorders and their impact on the host response to infection.The immunopathogenesis of sepsis in elderly patients.Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis.Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea.Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records.Epidemiology of hospital-acquired infections in veterans with spinal cord injury and disorder.Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II in predicting hospital mortality of neurosurgical intensive care unit patients.The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation.The role of infection and comorbidity: Factors that influence disparities in sepsis.Outcome of Noncardiac Surgical Patients Admitted to a Multidisciplinary Intensive Care Unit.Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome.Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit.Risk factors of organ failure in patients with bacteremic cholangitis.A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.Risk factors for 90-day and 180-day mortality in hospitalised patients with pressure ulcers.Factors associated with life-sustaining treatment restriction in a general intensive care unit.Patients with diabetes in the intensive care unit; not served by treatment, yet protected?Diabetes and hemoglobin a1c as risk factors for nosocomial infections in critically ill patients.Incidence of and risk factors for nosocomial bloodstream infections in adults in the United States, 2003.Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.Determinants of hospital mortality among patients with sepsis or septic shock receiving appropriate antibiotic treatment.Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.Contemporary epidemiology and prognosis of septic shock in infective endocarditis.Crude reality versus data manipulation: is the glass always crystal clear?The use of economic modeling to determine the hospital costs associated with nosocomial infections.Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study.
P2860
Q24550651-DBB71EFE-C275-46DB-A780-523C5086DE5EQ24601189-9C2B56DB-77EE-4081-9D95-E2517B267F4AQ24794938-B20F7AFB-2157-4572-B9C8-0367F0C8C5C8Q27687123-7A729ED1-0AEC-4723-9872-1B92EF6BF96DQ31171527-EBFC28D0-C29E-4274-B0DF-EA096C6E9776Q33277658-7D4C7905-0642-4496-98DD-0330199FB737Q33873426-2ACF91F7-2EC9-4728-AB12-FDFCCD5AA233Q34088730-7C6C16B1-3AFA-43BB-A718-F753B5466597Q34921923-73F1A4D8-1557-42C9-B9C5-02F7EB44AC6AQ35089779-00DA3B88-12D1-40FF-ABD8-9649B2D879AAQ35509100-CD860043-8165-4571-B061-6D2728565DE4Q35544626-FBEC2EFF-9F3E-40B7-828C-F0EDA9887346Q35996888-96F8FFC4-215D-401C-A560-2101D9DBC704Q36291747-D85D2B3C-4BFF-48E5-898B-C7F8A720EAF9Q36291760-CDD1EC69-2421-45E1-99DF-9C2A21887978Q36293944-AD3C7C77-3DC3-4679-BC04-8DD64D69F725Q36295036-119697F6-48DE-4DC7-96C8-8165E991CC91Q36381890-D8652458-5B1C-4548-B93E-B9277281D0B9Q36513113-F28C4FAA-6797-427D-97D0-D7DFDC52FE42Q37076322-3C2C8DB7-757D-49E0-ABE4-01C70C965FB9Q37232029-C782C205-D07D-458A-B28E-A6D1A9A3CB70Q37270943-B2A1D188-5F5C-45D0-A429-3ABF8CFEC09CQ37588175-FBE42F72-84B2-4EA6-95ED-084832C9D992Q37612745-DCBDF07C-D36A-4E46-961D-044DFB18FD7CQ37645053-6C1820D7-BB61-4DC5-BE5D-EB2A3079A0ACQ37857543-DF459BB2-4768-400D-A235-441350AA0E79Q38062337-F0ABF8F1-CD97-41B2-BD15-BAA86BE669B4Q39473178-0E1FAC04-B760-48F7-9DEA-73179DF26765Q40044387-930D75AC-7B0E-4E4C-9EAD-C9E623DB0725Q41047750-FCB55B23-3FFF-4B70-AE19-6443210EA67AQ41128540-214E809A-3484-4469-B659-7B1E978D1D8BQ41868537-0C64C413-B067-474D-96AD-517028B9FB1AQ43488583-6DA62BD4-8676-401F-9181-5D9AB3CD138EQ43756833-90ADF1A5-FC74-42E2-B930-8CF4A0C14E95Q44077587-C7A136C0-3B38-4FD8-B582-32593EA036FDQ44417867-609C829B-5097-410F-8AC8-925CC54AA52CQ44480634-27F1952D-5840-401E-8C2C-16191597F67CQ44892303-3FB05C41-67C2-4BD5-890E-E9915323E4F3Q47887562-BB27C4F0-026E-4B8C-9B52-896AEB89EF4CQ51155709-86C39730-0931-4E04-BD9B-1B89A8753A1C
P2860
Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Importance of pre-existing co- ...... ia in critically ill patients.
@en
Importance of pre-existing co- ...... ia in critically ill patients.
@nl
type
label
Importance of pre-existing co- ...... ia in critically ill patients.
@en
Importance of pre-existing co- ...... ia in critically ill patients.
@nl
prefLabel
Importance of pre-existing co- ...... ia in critically ill patients.
@en
Importance of pre-existing co- ...... ia in critically ill patients.
@nl
P2093
P2860
P356
P1476
Importance of pre-existing co- ...... ia in critically ill patients.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01690546
P577
1993-01-01T00:00:00Z